BRIDGE Webinar: Cell Line Development

How to bridge the gap from research to commercialization

Cell line development is a crucial step in taking biologics from discovery to the clinic and often represents the first major hurdle in the “valley of death.” The SciLifeLab Drug Discovery and Development platform now includes a Cell Line Development facility that will help bridge the gap to the clinic for early-stage projects. In this webinar, Niklas Berndt Thalén from SciLifeLab will present the cell line development process, explain why this step is essential for generating clinical-grade material, and outline what the new facility at DDD can offer. REGISTER HERE The Bridge webinar series is aimed at researchers, start-up and scale-up companies, as well as organisations within the innovation support system engaged in the development of biological products and pharmaceuticals. Don’t miss this opportunity to learn how to bridge the gap from research to commercialization.

---

ABOUT BRIDGE Running for 3 years and supported by SweLife through the Swedish Innovation Agency, Vinnova, BRIDGE aims to create a development platform spanning from identifying drug candidates to production.  Project start: 2024. PROJECT PARTNERS Testa Center (Project Coordinator): A national “open access” laboratory and production environment for academics and companies looking to verify and upscale their biological process for large-scale production. SciLifeLab Drug Discovery and Development Platform (DDD): A national research infrastructure providing state-of-the-art technology and expertise in drug development, from small molecules, biological pharmaceuticals, therapeutic oligonucleotides, and new modalities, from concept to preclinical stage. Stem Cell Center & Pre-GMP Lund University (LU): Conducting research in cell, tissue, and gene therapy, and supporting researchers with pre-GMP services to bridge the gap from research findings to patient care. These units also closely collaborate with the ATMP center (SUS), a node for Region Skåne’s work with ATMP treatments. STUNS: Foundation for collaboration between universities in Uppsala, industry, and society, promoting co-creation at the intersection of universities, industry, and society to create new opportunities. ALIS (Association of Life Science Incubators): A national platform that brings together nine regional life science incubators (GU Ventures, KI Innovations, Lead, Medeon, Sahlgrenska Science Park, Smile Incubator, STING, Umeå Biotech Incubator och Uppsala Innovation Center) tasked with supporting and guiding startups and research groups in skills development, business development, coaching, and access to national and international private capital